- Home
- TSHA vs BGR Comparison
TSHA vs BGR Comparison
Compare TSHA & BGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- BGR
- Stock Information
- Founded
- TSHA 2019
- BGR 2004
- Country
- TSHA United States
- BGR United States
- Employees
- TSHA N/A
- BGR N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- BGR Trusts Except Educational Religious and Charitable
- Sector
- TSHA Health Care
- BGR Finance
- Exchange
- TSHA Nasdaq
- BGR Nasdaq
- Market Cap
- TSHA 313.6M
- BGR 345.4M
- IPO Year
- TSHA 2020
- BGR N/A
- Fundamental
- Price
- TSHA $1.53
- BGR $13.47
- Analyst Decision
- TSHA Strong Buy
- BGR
- Analyst Count
- TSHA 8
- BGR 0
- Target Price
- TSHA $6.63
- BGR N/A
- AVG Volume (30 Days)
- TSHA 2.3M
- BGR 73.3K
- Earning Date
- TSHA 11-13-2024
- BGR 01-01-0001
- Dividend Yield
- TSHA N/A
- BGR 6.02%
- EPS Growth
- TSHA N/A
- BGR N/A
- EPS
- TSHA N/A
- BGR 0.69
- Revenue
- TSHA $9,915,000.00
- BGR N/A
- Revenue This Year
- TSHA N/A
- BGR N/A
- Revenue Next Year
- TSHA N/A
- BGR N/A
- P/E Ratio
- TSHA N/A
- BGR $18.97
- Revenue Growth
- TSHA N/A
- BGR N/A
- 52 Week Low
- TSHA $1.19
- BGR $11.38
- 52 Week High
- TSHA $4.32
- BGR $13.37
- Technical
- Relative Strength Index (RSI)
- TSHA 34.16
- BGR 66.12
- Support Level
- TSHA $1.56
- BGR $13.00
- Resistance Level
- TSHA $1.75
- BGR $13.50
- Average True Range (ATR)
- TSHA 0.16
- BGR 0.17
- MACD
- TSHA -0.02
- BGR 0.09
- Stochastic Oscillator
- TSHA 3.57
- BGR 91.67
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About BGR BlackRock Energy and Resources Trust
BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.